Estimated cost of universal public coverage of prescription drugs in Canada
about
Universal prescription drug coverage in Canada: Long-promised yet undeliveredMedication access via hospital admission.L’accès aux médicaments par l’hospitalisationA Global Perspective on Cardiovascular Disease in Vulnerable Populations.The potential exploitation of research participants in high income countries who lack access to health careThe Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider PerspectivesNational pharmacare: Time to move forward.[Assurance-médicaments nationale: Le moment d'aller de l'avant].Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.Trends in antidepressant prescribing to children and adolescents in Canadian primary care: A time-series analysis.A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec.Policy Capacity for Health Reform: Necessary but Insufficient: Comment on "Health Reform Requires Policy Capacity".Canada can afford universal pharmacare – no more excusesA letter to our colleague, Canada's new Minister of Health.Why the federal government must lead in health care.Leadership.The case for an essential medicines list for Canada.Testing and treatment for obstructive sleep apnea in Canada: funding models must change.Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs.Evaluating the effects of Quebec's private-public drug insurance system.Health Services Research Spending and Healthcare System Impact Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal".Drug prices: How do we get to a better place?Drug coverage in Canada: gaps and opportunities.Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.Cost-related nonadherence to prescription medications in Canada: a scoping reviewPrescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare
P2860
Q28069734-7324E7AD-BAD6-49A4-84A9-75D088390354Q33675478-81D3F3AB-3798-48AB-9185-C4B7D6DC0731Q33675487-AF510294-0555-4505-9D4A-44B3A747585CQ36676023-0C9A550D-84A8-46AC-B4AE-0DABA3F1AB88Q36806612-0EB3101F-F599-4690-A3AB-2707362CB87FQ36997039-C8178E87-9F59-4458-B1F5-EFA0CCACE3A0Q37112999-321D0219-FFC8-4C4F-827A-4FA727420E65Q37113030-9FEFD777-1F21-43D8-9605-774B32570959Q37666110-DAA20761-BFD1-42CF-B521-E10B377CB2F5Q38736791-94307596-6645-4760-AB5C-9080AF7B6221Q40995361-B64EBCE8-96D8-493B-A9C9-5DBB9DC784DDQ41080901-15C55A1A-C857-477E-95F6-D550FFE967E2Q41765071-1EAAB202-4986-42FE-A6F1-E8A6E29A1E1FQ42616763-13BA10FF-4500-4EBA-A4FC-F74A0D224845Q43111805-A6D3A03B-7176-4ED9-9072-54F5757164DAQ43140938-918B5F6F-E95A-485B-987A-E70C0787D806Q43200944-A32C51F9-4728-4B3E-B44A-A09C92321EE7Q45874109-7F561B63-DBAA-46B3-A2E9-D5DD6088C19CQ47260373-57D522EE-C24E-474B-92B1-D16DD201EAF8Q47406180-58BDA9A3-1862-4511-A649-53B2C12F7EFAQ50091332-A002ACCA-6CDD-4859-AB86-5DE83B0AA9ECQ52662927-1D34664A-95D1-4142-AA47-D662DEF944B2Q54234525-05C395D7-E70A-40BE-A8D3-88F17B30BDD0Q55101483-861C3152-C4CD-4BCA-9FBF-2A463BF1546CQ55435385-3094E0E8-EF49-4B56-99BD-BDCAB4F209C6Q58761551-B019DECB-10E2-45A1-B653-E6AF5B201CB9Q59133098-8A5914E4-82C9-470E-8A76-9D9DEE91EF60
P2860
Estimated cost of universal public coverage of prescription drugs in Canada
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Estimated cost of universal public coverage of prescription drugs in Canada
@ast
Estimated cost of universal public coverage of prescription drugs in Canada
@en
Estimated cost of universal public coverage of prescription drugs in Canada
@nl
type
label
Estimated cost of universal public coverage of prescription drugs in Canada
@ast
Estimated cost of universal public coverage of prescription drugs in Canada
@en
Estimated cost of universal public coverage of prescription drugs in Canada
@nl
prefLabel
Estimated cost of universal public coverage of prescription drugs in Canada
@ast
Estimated cost of universal public coverage of prescription drugs in Canada
@en
Estimated cost of universal public coverage of prescription drugs in Canada
@nl
P2093
P2860
P356
P1476
Estimated cost of universal public coverage of prescription drugs in Canada
@en
P2093
Danielle Martin
Jamie R Daw
Liza Abraham
Michael Law
Steven G Morgan
P2860
P304
P356
10.1503/CMAJ.141564
P407
P577
2015-03-16T00:00:00Z